YOUR PARTNER OF CHOICE
Extensive and accurate evaluation of the test systems, in collaboration with the respective experts and scientific institutes, are the basis for reliable results in routine serodiagnostics. In addition, MIKROGEN provides excellent scientific as well as technical know-how and assistance. MIKROGEN develops, produces and distributes test systems for the medical laboratory diagnosis in the field of bacterial and viral infectious diseases as well autoimmune diseases. Our innovative products are leading in the market of medical laboratory diagnosis. MIKROGEN combines genetical engineering know-how with scientific background and uncompromising customer orientation.
News
- Yersinia IgG 2.0
Yersinia IgA [IgM] 2.0
NEW: Yersinia Line-Assay with species-specific antigens
The new recomLine Yersinia assays are the first test systems that allow a serological differentiation between a Y. enterocolitica and a Y. pseudotuberculosis infection! - Treponema IgG
Treponema IgM
The easier, the better: Our new recomLine Treponema IgG, IgM
Confirmation of syphilis infections is greatly simplified. | Test procedure identical to recomLine HCV and recomLine HIV. - New screening ELISA product line: alphaWell
Mikrogen is now offering one of the most extensive product ranges for infectious serology. New in our program is the ELISA product line alphaWell: Screening ELISA for virtually all infectious agents. Product overview - HIV-1 & HIV-2 IgG
New: Confirmation assay recomLine HIV-1 & HIV-2 IgG
Excellent sensitivity and specificity | short incubation | automatic processing and analysis | The recomLine HIV-1 & HIV-2 IgG test solely uses recombinant antigens based on the ENV, POL and GAG gene segments and allows simple and safe confirmation of HIV screening results. - HCV IgG
NEW: recomLine HCV IgG – new line assay test system
The recomLine HCV IgG assay is using only recombinant antigens from the region Core, NS3, NS4 and NS5 and allows an easy and a reliable confirmation of HCV screening results. - New recomWell EBV ELISA
Safe detection of past infections | Reliable detection of primary EBV infections already in the early phase Product overview
Last changed: 03.02.2012